Sign In
Buy IINN
$0.380
+0 (+0%)
At Close: Jul 31, 2026
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
08:30am, Wednesday, 03'rd Apr 2024
RA'ANANA, Israel , April 3, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is del
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
08:00am, Monday, 01'st Apr 2024
RA'ANANA, Israel , April 1, 2024 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), today announced a strategic investment by leading investor, Mr
Inspira™ Technologies Reports Full Year 2023 Financial Results
09:20am, Monday, 25'th Mar 2024
FDA Submission for approval of INSPIRA™ ART100 95% Accuracy Results for HYLA™ Blood Sensor Compared to Standard Blood Gas Analyzers Granted U.S. Patent for INSPIRA™ ART Medical Device RA'ANANA,
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
02:11pm, Tuesday, 19'th Mar 2024
The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART).
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
07:00am, Monday, 18'th Mar 2024
RA'ANANA, Israel , March 18, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, is excited to a
Inspira Technologies (IINN) Releases Favorable Data on VORTX
11:21am, Thursday, 14'th Mar 2024
Inspira Technologies' (IINN) proprietary orbiting oxygenation technology eliminates the need for membrane fibers, thereby reducing pressure differentials and high shear stress.
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
08:00am, Tuesday, 12'th Mar 2024
An unprecedented achievement of a zero pressure gradient measured when using the VORTX™ device, directly correlating with a decrease in markers of blood damage. The performance of the VORTX™, t
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
09:20am, Monday, 04'th Mar 2024
The major milestone refers to Inspira's proprietary technology to oxygenate blood for the INSPIRA™ ART (Gen 2). This patented tech is considered by Inspira to be a game-changer and also aims to rep
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
07:02am, Tuesday, 27'th Feb 2024
RA'ANANA, Israel , Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology c
RA'ANANA, Israel , Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology com
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
07:00am, Thursday, 22'nd Feb 2024
RA'ANANA, Israel , Feb. 22, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology co
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
07:30am, Wednesday, 14'th Feb 2024
94% of the Claims Were Found to be Novel RA'ANANA, Israel , Feb. 14, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologi
Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
09:00am, Thursday, 08'th Feb 2024
T h e parties have entered a non-binding Letter of Intent RA'ANANA, Israel , Feb. 8, 2024 /PRNewswire/ -- Inspira Technologies OXY BHN Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira")
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
08:30am, Tuesday, 30'th Jan 2024
The agreement to potentially provide Inspira Technologies with $32.6 million over a 5-year period, subject to regulatory approvals RA'ANANA, Israel , Jan. 30, 2024 /PRNewswire/ -- Inspira Technologies
The kit is being designed for the INSPIRA™ ART device series and is intended to be compatible with various life support machines sold in the market RA'ANANA, Israel, Jan. 9, 2024 /PRNewswire/ -- I
